• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Public Health (Oxf) . Rate of reinfections after SARS-CoV-2 primary infection in the population of an Italian province: a cohort study

tetano

Editor, Senior Moderator
J Public Health (Oxf)


. 2021 Sep 8;fdab346.
doi: 10.1093/pubmed/fdab346. Online ahead of print.
Rate of reinfections after SARS-CoV-2 primary infection in the population of an Italian province: a cohort study


M E Flacco[SUP] 1 [/SUP], C Acuti Martellucci[SUP] 1 [/SUP], G Soldato[SUP] 2 [/SUP], R Carota[SUP] 3 [/SUP], P Fazii[SUP] 4 [/SUP], A Caponetti[SUP] 5 [/SUP], L Manzoli[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Current data suggest that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections are rare, but no information are available on minors and after 12 months of follow-up.
Methods: This retrospective cohort study included all the population of an Italian Province, diagnosed with a SARS-CoV-2 infection from March 2020 to May 2021. The primary outcome was the incidence of a reinfection, defined as a new positive polymerase chain reaction (PCR) test occurring ≥90 days after complete resolution of the first infection, and data were retrieved from the official datasets (coronavirus disease 2019 [COVID-19], demographic, hospital and co-pay exemption) of the Local Health Unit (LHU) of Pescara.
Results: After an average of 201 days of follow-up (max. 414), we recorded 24 reinfections ≥90 days after the resolution of the first 7173 infections (0.33%). Four reinfections required hospitalization, one was lethal. Most of the reinfections (n = 13) occurred 6-9 months after the resolution of the first infection; no new infection was detected 12 or more months later and among the 832 minors.
Conclusions: This study confirms previous findings on a low risk of SARS-CoV-2 reinfection. If confirmed, these findings suggest that more targeted restriction policies can be applied to the subjects that recovered after a first infection.

Keywords: COVID-19; Italy; SARS-CoV-2; reinfection; relapse.
 
Back
Top Bottom